Skip to content

HEALTH CATALYST, INC.

HCAT

CIK 0001636422

Revenue (TTM)
$307.21M
+1.5% YoY Q1 May 2026
Net Income (TTM)
−$197.98M
−156.1% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.79
−121.7% YoY Q1 May 2026
Gross Margin
Q1 May 2026
Operating Margin
-59.0%
Q1 May 2026
Net Margin
-64.4%
Q1 May 2026
Free Cash Flow (TTM)
$21.84M
Q1 May 2026
Cash
$59.86M
Q1 May 2026
Total Debt
$153.37M
Q1 May 2026
Shares Outstanding
73.89M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings